J
Research Areas
Biography and Research Information
OverviewAI-generated summary
James S. Cordova's research focuses on the clinical outcomes and treatment patterns for various cancers, particularly glioblastoma and soft tissue sarcomas. His work includes investigating the efficacy of chemotherapy agents like Belinostat in combination with chemoradiation for newly diagnosed glioblastoma. Cordova has also studied the use of advanced imaging techniques, such as 3D whole-brain metabolite imaging and FDOPA PET, to improve the characterization and targeting of gliomas for radiation therapy. His publications also address brachytherapy techniques for gynecological cancers and soft tissue sarcomas, examining outcomes and failure patterns. Cordova's research network includes collaborators such as Faraz Kalantari and Forouh Kalantari from the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications. His scholarship metrics include an h-index of 12, 36 total publications, and 517 total citations.
Metrics
- h-index: 12
- Publications: 36
- Citations: 525
Selected Publications
-
Interstitial Brachytherapy for Soft Tissue Sarcomas: Outcomes and Patterns of Failure Patterns from a Single Institution Experience (2025)
Collaboration Network
Top Collaborators
Vicki Huang
Georgia Institute of Technology (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Saumya Gurbani
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Karthik Ramesh
Georgia Institute of Technology (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Eduard Schreibmann
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Hui‐Kuo G. Shu
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Jeffrey J. Olson
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Hyunsuk Shim
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Brent D. Weinberg
Emory University (US)
3 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Karen M. Xu
Emory University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Soma Sengupta
Emory University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Alfredo Voloschin
Emory University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Matthias Holdhoff
Johns Hopkins University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Peter B. Barker
Johns Hopkins University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Lawrence Kleinberg
Johns Hopkins University (US)
2 shared publications
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) With Chemoradiation for Newly Diagnosed Glioblastoma
Randall Brenneman
Washington University in St. Louis (US)
2 shared publications
- Impact of ITV/GTV Ratio on Local Failure in Early Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Ablative Radiation Therapy
- The Influence of Neighborhood Socioeconomic Status and Follow-up on Survival in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy
Similar Researchers
Based on overlapping research topics
Somayeh Gholami
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Radiation Therapy and Dosimetry
Stetson Van Matre
University of Central Arkansas
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Radiation Therapy and Dosimetry
Wen C. Hsi
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Radiation Therapy and Dosimetry
April Jules
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Radiation Therapy and Dosimetry
Jesse D. Ivers
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Cancer Cells and Metastasis
S. Acklin
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Medical Imaging Techniques and Applications
Radiation Therapy and Dosimetry